SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Eisai and Biogen Make LEQEMBI Pen Available in Japan

The companies said the subcutaneous formulation of LEQEMBI is now available in Japan for patients with early Alzheimer’s disease.

4523BIIB

Related stories